Final results of the phase II, single arm trial of irinotecan and cisplatin in children with high-risk glial tumors.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.10549
Abstract: 10549Background: We conducted an open label, single arm phase II clinical trial with irinotecan and cisplatin (I/C) for pediatric patients with glial tumors (EudraCT:2009-010742-59). Methods: Patie... read more here.
Keywords: glial tumors; trial irinotecan; single arm; irinotecan cisplatin ... See more keywords